Nonselective HDAC inhibitors like A452 induce synergistic cytotoxicity of MM without modifying CRBN expression combined with IMiDs, thus downregulating IKZF1/3, c-Myc, and IRF4 (Won et al., 2019). This evidence concerns the gene IKZF1 and Miyoshi myopathy.